AI assistant
Sending…
Wave Life Sciences Ltd. — Director's Dealing 2021
Mar 25, 2021
31900_dirs_2021-03-24_ef128dd4-cb8a-45cc-a89b-4e080a9fa0bd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2021-03-24
Reporting Person: Moran Kyle (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-24 | Ordinary Shares | M | 10930 | $2.48 | Acquired | 80792 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-24 | Share Option (right to buy) | $2.48 | M | 10930 | Disposed | 2025-03-10 | Ordinary Shares (10930) | Direct |
Footnotes
F1: The share options that were exercised in this reportable transaction are fully vested.
More from Wave Life Sciences Ltd.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 15
Major Shareholding Notification
2026
Mar 31
Director's Dealing
2026
Mar 31
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 28
Annual Report
2026
Feb 26